共 2 条
Sorafenib for relapsed FLT3-ITD-positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
被引:1
作者:
Brodie, Rachel
[1
]
Langabeer, Stephen E.
[2
]
Quinn, John
[3
]
McMenamin, Mairin E.
[4
]
Hayden, Patrick J.
[1
]
机构:
[1] St James Hosp, Dept Haematol, Dublin, Ireland
[2] St James Hosp, Canc Mol Diagnost, Dublin D08 RX0X, Ireland
[3] Beaumont Hosp, Dept Haematol, Dublin, Ireland
[4] St James Hosp, Dept Histopathol, Dublin, Ireland
来源:
CLINICAL CASE REPORTS
|
2019年
/
7卷
/
12期
关键词:
acute myeloid leukemia;
allogeneic stem cell transplantation;
FLT3;
mutation;
leukemia cutis;
relapse;
sorafenib;
D O I:
10.1002/ccr3.2487
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Relapse of FLT3-mutated acute myeloid leukemia (AML) following allogeneic stem cell transplantation is associated with poor survival. The clinical utility of sorafenib monotherapy in this setting is described in a patient presenting as leukemia cutis.
引用
收藏
页码:2579 / 2580
页数:2
相关论文